Description: Profound Medical Corp. operates as a medical device company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids, and palliative pain treatment of bone metastases. The company is headquartered in Mississauga, Canada.
Home Page: www.profoundmedical.com
PRN Technical Analysis
2400 Skymark Avenue
Mississauga,
ON
L4W 5K5
Canada
Phone:
647 476 1350
Officers
| Name | Title |
|---|---|
| Dr. Arun Swarup Menawat MBA, Ph.D. | Chairman & CEO |
| Mr. Rashed Dewan | Chief Financial Officer |
| Dr. Mathieu Burtnyk | Sr. VP of Product Leader TULSA-PRO |
| Mr. Stephen Kilmer | Investor Relations |
| Mr. Hartmut Warnken | Chief Commercial Officer of OUS |
| Mr. Jacques F. Cornet | Sr. VP & Product Leader Sonalleve |
| Mr. Michael Mydra | VP & Head of Global Market Access |
| Mr. Abbey Goodman | Chief Commercial Officer of US |
| Mr. Matthew Sobczyk C.A., CPA | Assistant Corp. Controller |
| Mr. Levant Tinaz | Software Developer |
Exchange: TO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.2164 |
| Price-to-Sales TTM: | 38.8459 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 146 |